Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH

Keyphrases

• PEGylated 100%
• Lipoatrophy 100%
• Polyethylene Glycol 100%
• Placebo 28%
• Recombinant Human 28%
• Injection Site 28%
• Adult GH Deficiency 28%
• Multiple Dose 14%
• Placebo Groups 14%
• Placebo-controlled 14%
• Insulin-like Growth factor-1 14%
• Treatment Group 14%
• Randomized Double-blind 14%
• Group Studies 14%
• GH Deficiency 14%
• Covalent Binding 14%
• First Injection 14%
• D-groups 14%
• Long-acting GH 14%
• Weekly Injection 14%
• Daily Injection 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Lipoatrophy 100%
• Macrogol 100%
• Placebo 57%
• Growth Hormone Deficiency 42%
• Insulin-Like Growth Factor 1 14%
• Treatment Group 14%